Large investments from some of the world’s biggest drugmakers are pouring into Singapore as companies seek to expand production in the city-state and access broader Asia, one of the fastest-growing markets with a rapidly aging population.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
